FDA Approves Label Expansions, New Indication for Bempedoic Acid Tablets for CV Prevention
The approval represents the first non-statin treatment indicated to lower low-density lipoprotein for primary prevention patients.
Slideshow: Pharmacist Interventions Are Key in Addressing the Mental Health Crisis
Four posters presented at this year’s American Pharmacists Association Annual Meeting & Exposition assessed the potential impact of pharmacist interventions on improving mental health outcomes.
Pharmacists Address Their Role in Adolescent Vaping Education
According to posters presented at the 2024 American Pharmacists Association Annual Meeting and Exposition, pharmacists wish to play a bigger role in educating young people about the risks of vaping.
Slideshow: Assessing the COVID-19 Pandemic After its 2020 Peak
Four posters presented at the American Pharmacists Association Annual Meeting and Exposition explored how individuals and health care providers have been handling the COVID-19 pandemic.
Veterans Reported Loss of Everyday Functioning After COVID-19 Pandemic
Researchers aimed to address the adverse effects of veterans with COVID-19 diagnoses 18 months after infections were documented.
How "Scope Creep" Can Save Health Care
In its ongoing campaign against “scope creep,” the American Medical Association argued that pharmacists don’t receive enough training. Physicians and pharmacists alike disagree.
Adaptation Is the Key to Success
Farmers and welders have adapted to work with the current times. Pharmacists should consider adapting their profession as well.
FDA Approves Rilpivirine For Treatment of HIV-1 in Pediatric Patients
Rilpivirine (Edurant Ped) effectively suppresses the HIV-1 virus in pediatric patients with HIV-1 RNA less than or equal to 100,000 copies/mL in combination with other antiretroviral therapies.
Navigating Pediatric ADHD Medication Shortages
Stimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.
Local Pharmacy Access in the United States Significantly Lower in Rural Areas
Researchers collected data to measure inequities in pharmacy access across the country.
Dispensing Hope: How Pharmacists Are Advocating for Abortion Access
Supreme Court decisions and state-level legislation have made abortion access in some states more complicated than ever before.
OTC Product Roundup: Women's Health
These OTC products are recommended to address a variety of symptoms associated with women's health issues.
Focus On Obesity Management Before Addressing Comorbidities
The latest guidelines advise managing obesity first, then treating a patient’s other conditions to produce optimal outcomes.
Meeting Preview: APhA 2024
APhA 2024 will take place March 22 to March 25 in Orlando, Florida.
Vaccines to Watch in 2024
Moderna, Merck, and Pfizer-BioNTech are leading the charge with new vaccines for respiratory viruses in development.
Pharmacist Education, Knowledge Key to Fostering Biosimilar Adoption
Despite the significant growth of biosimilars, their adoption across various therapeutic areas has remained slow.
FDA Grants Clearance to twiist Automated Insulin Delivery System for T1D
Efficacy of Tapinarof Cream 1% Demonstrated in Atopic Dermatitis in Skin of Color
A lack of diversity in clinical trials has hampered health care providers from understanding the nuances of diseases across specific patient populations.
AstraZeneca Caps Out-of-Pocket Inhaler Costs at $35 Per Month
AstraZeneca is the second pharmaceutical company to cap out-of-pocket costs for eligible patients.
Hypertension Interventions Have Limited Success in Rural Black Populations
Hypertension remains a significant problem in areas of the rural South.
In This Issue: Drug Topics March 2024
See what's trending in pharmacy with a preview the Drug Topics March issue.
Small Doses: March 11 to March 15
Check out a recap of important pharmacy news you might’ve missed this week, dispensed in small doses.
Telehealth-Based OUD Treatment May Lead to Better Health, Obstetric Outcomes Among Pregnant Patients
Telehealth mitigates barriers like stigma, fear, and legal concerns associated with receiving opioid use disorder (OUD) care by offering a convenient and discreet treatment option.
FDA Approves Lisocabtagene Maraleucel For Treatment of Relapsed or Refractory CLL, SLL
The approval was based on data from the phase 1/2 TRANSCEND CLL 004 study, in which the CAR T cell therapy demonstrated statistically significant complete response rates.
FDA Approves Resmetirom as First-Ever Treatment For MASH
The approval, awarded to Madrigal Pharmaceuticals, was based on phase 3 data demonstrating that resmetirom achieved broad treatment effects in patients with MASH with liver fibrosis.
Interventional Techniques Can Help Manage Pain in Patients With Cancer
With growing concerns around opioid use disorder, interventional pain management for patients with cancer can provide effective relief without the side effects associated with medication.
California Wildfires in the 2010s Exacerbated Psychotropic Medication Prescriptions
Researchers studied the effect of wildfires on mental health in California from 2011 to 2018.
How Daylight Saving Time Increases Overall Health Risks
Recent studies on daylight saving time’s association with increased health risks have heightened the debate on whether to observe the biannual event or switch to one universal time.
CDC Says US Will Transition to Trivalent Vaccines Next Flu Season
Since changes in vaccine composition can sometimes lead to confusion or misinformation, effective communication is crucial to promote vaccine uptake.
Psilocybin Analog for Treatment of Depression Receives FDA Breakthrough Therapy Designation
Cybin’s proprietary deuterated psilocybin analog, CYB003, provided robust and sustained improvements in depression symptoms in a phase 2 study.